Physician

Michael Jaworski, M.D.

According to 2025 Medicare claims, Michael Jaworski, M.D. (NPI: 1013035492) practices rheumatology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Chester, PA. This provider's primary affiliated billing organization is CHESTER COUNTY RHEUMATOLOGY PC (NPI: 1225214778; TIN: 261724004) and primary practice location at 19380-4400.

Jaworski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 827 traditional Medicare patients, billed 159,479 HCPCS/CPT codes, and received $3,261,745 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,792 prescription claims across 362 beneficiaries totaling $1,747,118 in drug costs, led by Octagam (Immun Globg(Igg)/Malt/Iga Ov50). DME data shows 24 claims. Open Payments data shows 222 records totaling $4,313. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,334,671 to $3,261,745. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $351,148 to $1,747,118. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	494	39,565	$1,334,671
2016	476	40,258	$1,674,223
2017	499	63,369	$2,349,538
2018	604	80,619	$3,018,403
2019	715	81,703	$2,476,209
2020	740	78,903	$2,548,542
2021	758	108,146	$2,686,618
2022	739	115,691	$2,452,637
2023	748	130,753	$2,623,318
2024	827	159,479	$3,261,745

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	336	1,858	$351,148
2016	342	1,968	$324,344
2017	320	1,720	$293,128
2018	319	1,755	$422,331
2019	314	1,760	$621,405
2020	327	1,997	$1,243,714
2021	345	1,876	$1,141,000
2022	336	1,820	$1,205,723
2023	325	1,755	$1,607,377
2024	362	1,792	$1,747,118

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	11	$32,805
2024	N/R	24	$38,575

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	158	678	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	485	830	$105
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	373	979	$64
J0897	Injection, denosumab, 1 mg	334	30,960	$20
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	259	365	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	15	420	$502,218
Privigen	Immun Glob G(Igg)/Pro/Iga 0-50	34	952	$399,217
Humira(Cf) Pen	Adalimumab	34	952	$312,413
Enbrel Sureclick	Etanercept	24	672	$180,474
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	12	336	$49,090

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	12	$34,619
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	12	$3,956

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	222	$4,313	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Jaworski, M.D.?

Tedicare shows public-source Medicare data for Michael Jaworski, M.D. (NPI 1013035492), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Jaworski, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Jaworski, M.D.?

Michael Jaworski, M.D. is linked to CHESTER COUNTY RHEUMATOLOGY PC (billing NPI 1225214778) in the available physician profile data.

Does Michael Jaworski, M.D. have Open Payments data?

Michael Jaworski, M.D. has 222 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.